Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics
Epilepsia Open · 2026
DOI: 10.1002/epi4.70340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia Open, 2026. Verfasst von Rima Nabbout und 20 weiteren Autor:innen. Beteiligte Einrichtung: Reference Centre for Rare Epilepsies, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Member of the European Reference Network (ERN) EpiCARE, Pa…. Hauptthemen laut MEDLINE: Fenfluramine, Epilepsies, Myoclonic, Anticonvulsants. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To assess the efficacy and safety of fenfluramine in patients with Dravet syndrome (DS) stratified by age, number of previously attempted antiseizure medications (ASMs), and SCN1A pathogenic variant status.
Methods
In this post hoc analysis, data from three randomized controlled trials (RCTs) in patients with DS (2–18 years) were pooled and stratified by age (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reference Centre for Rare Epilepsies, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Member of the European Reference Network (ERN) EpiCARE, Paris, France.
- Institut Imagine, INSERM 1163, Université Paris Cité, Paris, France.
- University of California San Francisco Weill Institute for Neurosciences, Benioff Children's Hospital, San Francisco, California, USA.
- AP-HP, Reference Center for Rare Epilepsies, Member of ERN EpiCARE, Hôpital Universitaire Robert Debré, Paris, France.
- Institut Hospitalo-Universitaire Robert-Debré du Cerveau de l'Enfant, Paris, France.
- INSERM NeuroDiderot, Université Paris-Cité, Paris, France.
ORCID-Profile: Rima Nabbout, Joseph Sullivan, Stéphane Auvin, J Helen Cross, Orrin Devinsky, Antonio Gil-Nagel, Kelly G Knupp, M Scott Perry, Rocío Sánchez-Carpintero, An-Sofie Schoonjans, Nicola Specchio, Adam Strzelczyk, James Wheless, Elaine C Wirrell, Amélie Lothe, Lieven Lagae
Zitieren
APA
Nabbout, R., Sullivan, J., Auvin, S., Cross, J. H., Devinsky, O., Gil-Nagel, A., Guerrini, R., Knupp, K. G., Perry, M. S., Sánchez-Carpintero, R., Schoonjans, A. S., Scheffer, I. E., Specchio, N., Strzelczyk, A., Wheless, J., Wirrell, E. C., Morita, D., Healy, P., Langlois, M., …, & Lagae, L. (2026). Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics. Epilepsia Open. https://doi.org/10.1002/epi4.70340
Vancouver
Nabbout R, Sullivan J, Auvin S, Cross JH, Devinsky O, Gil-Nagel A, et al. Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics. Epilepsia Open. 2026. doi:10.1002/epi4.70340
BibTeX
@article{Nabbout2026,
author = {Nabbout, Rima and Sullivan, Joseph and Auvin, Stéphane and Cross, J Helen and Devinsky, Orrin and Gil-Nagel, Antonio and Guerrini, Renzo and Knupp, Kelly G and Perry, M Scott and Sánchez-Carpintero, Rocío and Schoonjans, An-Sofie and Scheffer, Ingrid E and Specchio, Nicola and Strzelczyk, Adam and Wheless, James and Wirrell, Elaine C and Morita, Diego and Healy, Patrick and Langlois, Mélanie and Lothe, Amélie and Lagae, Lieven},
title = {Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics},
journal = {Epilepsia Open},
year = {2026},
doi = {10.1002/epi4.70340}
}
EUVIMED